Clinical trials: Stroke Recurrence

Patent Foramen Ovale, Stroke

PFO ACCESS Registry

• No Longer Available
• Age: All ages
• Expanded access
• Medical device

Closure of Patent Foramen Ovale with the AMPLATZER® PFO OCCLUDER in patients with at least two cryptogenic strokes due to presumed paradoxical embolism through a patent foramen ovale and who have failed conventional therapy.

Trial name

NCT00583401

Testing

Device closure with the AMPLATZER PFO Occluder

Sponsor

Abbott Medical Devices